CI
BSX icon

Corient IA’s Boston Scientific BSX Stock Holding History

Corient IA’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Hold
5,650
– – 0.22% 144
2026
Q1 		$355K Sell
5,650
-1,350
-19% -$108K 0.33% 111
2025
Q4 		$667K Hold
7,000
– – 0.63% 36
2025
Q3 		$683K Hold
7,000
– – 0.51% 52
2025
Q2 		$752K Hold
7,000
– – 0.44% 64
2025
Q1 		$706K Buy
+7,000
New +$705K 0.5% 45

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Corient IA's BSX Position: Q2 2026 in Review

Corient IA held its Boston Scientific (BSX) position steady in Q2 2026 at 5,650 shares worth $241K. The position accounts for 0.22% of the portfolio, ranked #144.

Corient IA first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $752K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Corient IA held 5,650 shares of Boston Scientific worth $241K as of Q2 2026.
  • Corient IA left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.22% of Corient IA's portfolio in Q2 2026, its #144 holding.
  • Corient IA first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Corient IA's Boston Scientific position peaked at $752K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.